Chrysa Mineo - 02 Jun 2025 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: Director
Signature: /s/ Shane Ward, Attorney-in-Fact
Issuer symbol: CDTX
Transactions as of: 02 Jun 2025
Net transactions value: +$73,896
Form type: 4
Filing time: 04 Jun 2025, 16:23:24 UTC
Previous filing: 19 Dec 2024
Next filing: 18 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mineo Chrysa	Director	6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO	/s/ Shane Ward, Attorney-in-Fact	04 Jun 2025	0001575644

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Purchase	$49,281	+2,270		$21.71	2,270	02 Jun 2025	Direct
transaction	CDTX	Common Stock	Purchase	$24,614	+1,050	+46%	$23.44	3,320	03 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.365 to $23.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.365 to $23.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.